ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2231

The Actin-Crosslinking Protein Lasp-1 Regulates Synovial Fibroblast Migration and Cartilage Destruction In Arthritis

Denise Beckmann1, Jan Hillen2, Marianne Heitzmann2, Catherine S. Chew3, Stefan Butz4, Dietmar Vestweber5, Hermann Pavenstädt6, Thomas Pap7 and Adelheid Korb-Pap2, 11nstitute of Experimental Musculoskeletal Medicine, University Hospital Muenster, Muenster, Germany, 2Institute of Experimental Muskuloskeletal Medicine, University Hospital Muenster, Muenster, Germany, 3Institute of Molecular Medicine and Genetics, Medical College of Georgia, Augusta, GA, 4Max Planck Institute of Molecular Biomedicine, Max Planck Institute of Molecular Biomedicine, Muenster, Germany, 5Max Planck Institute of Molecular Biomedicine, Muenster, Germany, 6Internal Medicine D, Department of Nephrology and Rheumatology, University Hospital Muenster, Muenster, Germany, 7Institute of Experimental Muskuloskeletal Medicine, University Hospital Münster, Münster, Germany

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Fibroblasts

  • Tweet
  • Email
  • Print
Session Information

Title: Rheumatoid Arthritis - Animal Models II

Session Type: Abstract Submissions (ACR)

Background/Purpose: Lasp-1 localizes at focal adhesions along stress fibres and leading edges of migrating cells and regulates the metastatic dissemination of tumors. Although rheumatoid arthritis synovial fibroblasts (RASF) have been shown to contribute to the spreading of disease by leaving cartilage destruction sites, migrating via the bloodstream and re-initiating the destructive process at distant articular cartilage surfaces, the underlying mechanisms are not yet understood. Therefore, we investigated the role of Lasp-1 in SF migration and in a mouse model of RA.

Methods: We used Western blot analyses and immunofluorescence stainings of cells grown on different extracellular matrices (ECM) including fibronectin, laminin and in vitro reconstituted cartilage collagen fibrils to study the expression of Lasp-1 and its sub-cellular distribution in RASF as well as in SF isolated from the hind paws of wild type (wt) and human TNFalpha transgenic (hTNFtg) mice, an established animal model of human RA. To investigate the effects of a Lasp-1 deficiency on RA-like arthritis in vivo, we interbred Lasp-1-/- mice with hTNFtg mice. Wt, Lasp-1-/-, hTNFtg and Lasp-1-/-/hTNFtg mice were scored for clinical parameters such as paw swelling, grip strength and weight once weekly for 14 weeks. Hind paws of 14 weeks old mice of all genotypes were harvested, embedded into paraffin, and tissue sections were stained with toluidin-blue and analyzed using AxioVision software. The migration characteristics of SF derived from all genotypes were studied in a modified scratch assay as well as in live cell imaging studies.

Results: Western blot analyses showed a significantly increased expression of Lasp-1 in RASF and in hTNFtg SF compared to healthy and wt controls. Using immunofluorescence, Lasp-1 was localized to structures of cell adhesion and invasion especially when in vitro reconstituted cartilage collagen fibrils were used as ECM. Quantification of scratch assay data showed a significantly reduced migration of Lasp-1-/- SF compared to wt cells (-43.7%, p<0.05) and even more prominently of Lasp-1-/-/hTNFtg SF compared to hTNFtg cells (-69.11%, p<0.05). Live cell imaging demonstrated striking differences both in the migration velocity and in migration edge formation of Lasp-1-/-/hTNFtg SF compared to hTNFtg SF in vitro. Lasp-1-/-/hTNFtg mice presented milder clinical symptoms compared to hTNFtg animals in vivo. Histopathologic analyses showed less cartilage damage in Lasp-1-/-/hTNFtg compared to hTNFtg mice (5.2% vs. 33.6%, p<0.05) and attachment of synovial tissue to the cartilage (0.4 µm vs. 1.4µm, p<0.05) at an age of 14 weeks.

Conclusion: We conclude that Lasp-1 modulates SF migration and influences cartilage degradation and SF attachment to cartilage in hTNFtg mice. SF – when activated – migrate through the formation of invasive and adhesive membrane structures, where Lasp-1 is prominently localized. Thus, targeting Lasp-1 may be a promising strategy to reduce the invasive and migratory behaviour of RASF.


Disclosure:

D. Beckmann,
None;

J. Hillen,
None;

M. Heitzmann,
None;

C. S. Chew,
None;

S. Butz,
None;

D. Vestweber,
None;

H. Pavenstädt,
None;

T. Pap,
None;

A. Korb-Pap,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-actin-crosslinking-protein-lasp-1-regulates-synovial-fibroblast-migration-and-cartilage-destruction-in-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology